|
|
Blood, 15 November 2005, Vol. 106, No. 10, pp. 3546-3552.
Prepublished online as a Blood First Edition Paper on July 28, 2005; DOI 10.1182/blood-2005-02-0493.
Previous Article | Table of Contents | Next Article 
NEOPLASIA
A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus
Sys Zoffmann Glud,
Annette Balle Sørensen,
Mindaugas Andrulis,
Bruce Wang,
Eisaku Kondo,
Randi Jessen,
Laszlo Krenacs,
Eva Stelkovics,
Matthias Wabl,
Edgar Serfling,
Alois Palmetshofer, and
Finn Skou Pedersen
From the Department of Molecular Biology, University of Aarhus, Aarhus, Denmark; the Department of Molecular Pathology, Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany; Picobella, Burlingame, CA; the Department of Pathology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; the Laboratory of Tumor Pathology and Molecular Diagnostics, Institute of Biotechnology, Bay Zoltan Foundation for Applied Research, Szeged, Hungary; the Department of Microbiology and Immunology, University of California, San Francisco, CA; and the Department of Medical Microbiology and Immunology, University of Aarhus, Aarhus, Denmark.
Nuclear factor of activated T cell (NFAT) transcription factors play a central role in differentiation, activation, and elimination of lymphocytes. We here report on the finding of provirus integration into the Nfatc3 locus in T-cell lymphomas induced by the murine lymphomagenic retrovirus SL3-3 and show that NFATc3 expression is repressed in these lymphomas. The provirus insertions are positioned close to the Nfatc3 promoter or a putative polyadenylated RNA (polyA) region. Furthermore, we demonstrate that NFATc3-deficient mice infected with SL3-3 develop T-cell lymphomas faster and with higher frequencies than wild-type mice or NFATc2-deficient mice. These results identify NFATc3 as a tumor suppressor for the development of murine T-cell lymphomas induced by the retrovirus SL3-3.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. H. Rasmussen, B. Wang, M. Wabl, A. L. Nielsen, and F. S. Pedersen
Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis
Nucleic Acids Res.,
August 1, 2009;
37(14):
4657 - 4671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H.T. Nguyen, M. Beland, Y. Gaitan, and M. Bouchard
Calcineurin A-Binding Protein, a Novel Modulator of the Calcineurin-Nuclear Factor of Activated T-Cell Signaling Pathway, Is Overexpressed in Wilms' Tumors and Promotes Cell Migration
Mol. Cancer Res.,
June 1, 2009;
7(6):
821 - 831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ejegod, K. D. Sorensen, I. Mossbrugger, L. Quintanilla-Martinez, J. Schmidt, and F. S. Pedersen
Control of Pathogenicity and Disease Specificity of a T-Lymphomagenic Gammaretrovirus by E-Box Motifs but Not by an Overlapping Glucocorticoid Response Element
J. Virol.,
January 1, 2009;
83(1):
336 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Robbs, A. L. S. Cruz, M. B. F. Werneck, G. P. Mognol, and J. P. B. Viola
Dual Roles for NFAT Transcription Factor Genes as Oncogenes and Tumor Suppressors
Mol. Cell. Biol.,
December 1, 2008;
28(23):
7168 - 7181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-D. Li, X. Zhang, R. Li, Y.-D. Wang, Y.-L. Wang, K.-J. Han, X.-P. Qian, C.-G. Yang, P. Liu, Q. Wei, et al.
CHP2 Activates the Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway and Enhances the Oncogenic Potential of HEK293 Cells
J. Biol. Chem.,
November 21, 2008;
283(47):
32660 - 32668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Akimzhanov, L. Krenacs, T. Schlegel, S. Klein-Hessling, E. Bagdi, E. Stelkovics, E. Kondo, S. Chuvpilo, P. Wilke, A. Avots, et al.
Epigenetic Changes and Suppression of the Nuclear Factor of Activated T Cell 1 (NFATC1) Promoter in Human Lymphomas with Defects in Immunoreceptor Signaling
Am. J. Pathol.,
January 1, 2008;
172(1):
215 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yao, Y.-Y. Cho, H. R. Bergen III, B. J. Madden, B. Y. Choi, W.-Y. Ma, A. M. Bode, and Z. Dong
Nuclear Factor of Activated T3 Is a Negative Regulator of Ras-JNK1/2-AP-1 Induced Cell Transformation
Cancer Res.,
September 15, 2007;
67(18):
8725 - 8735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dong, S. Kim, S. Hong, J. Das Gupta, K. Malathi, E. A. Klein, D. Ganem, J. L. DeRisi, S. A. Chow, and R. H. Silverman
From the Cover: An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
PNAS,
January 30, 2007;
104(5):
1655 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Wang, B. B. Wang, G. Bartha, L. Li, N. Channa, M. Klinger, N. Killeen, and M. Wabl
Activation of an oncogenic microRNA cistron by provirus integration
PNAS,
December 5, 2006;
103(49):
18680 - 18684.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|